ileditview hiDon't mind Spicer, he hazes newbies. He's been on...

ileditview hi

Don't mind Spicer, he hazes newbies. He's been on solagran for years
and by the sounds the sauce for more years. I remember from my own
psshead days, it leads to rapid mood swings and paranoia.

I am quite keen to hear more of why you believe SLA to be the one place
to invest (just that to concentrate all your resources on this one
play shows confidence in them). What was the previous mob you were on for 8 years, what about them (more specifics) lead you to ditch?

You are right to wonder if Dr Agishev has a vested interest. You
will have noticed there are alot of possibly-confusing relationships in the solagran
story. SLA Owning 25% of BPO has nothing to do with "Gun" Khourie? And former
creditor now largest shareholder Solana has nothing to do with Solamind...

There has been alot of posts here and elsewhere asserting that the
ropren drug trials did not have sufficient sample
sizes to be statistically robust. A mistrust of Russian
academic standards, where there is quite the industry in ghost-written PhDs
paid for by up and coming apparatchiks, might not be out of place. Our mate Vladimir Putin may be one former customer of such an industry.

http://www.timesonline.co.uk/tol/news/world/article695235.ece

I'm not saying that Dr Agishev got his qualifications out of a wheaties
box. He'd have to know at least a bit about psychiatric medicine to
stay director for 20 years. But he'd also have to be very adept at
hospital and scientific politics to stay in that position for 20 years.

Doctors the world over know the power they wield over pharma companies.
I personally don't mind how many palms have to get greased or how
many ticks this dog has got. If the reality for ropren sales
is even 5% of the hype then there's gonna be bucketloads of cash to go
around.

I don't mind that Dr Diedre O'Neill is the 10th biggest shareholder of
SLA in last top-20 I saw, at the same time as there is a (small, local) boom in
Ropren sales in NZ. It is natural to distrust sales that are
not occuring in a transparent marketplace. But it pays to accumulate powerful friends.

There was a ramble that went nowhere. Go SLA!